跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RANOZEK 750 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
RANOZEK 750 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG
Approved
STANDARD
RANOZEK 750 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG
Adamed Laboratorios S.L.U.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 19, 2022
Approval ID
f40876a7dc6edb70
Company
Adamed Laboratorios S.L.U.
Type
Standard
Approval Details
Approval Id
f40876a7dc6edb70
Drug Cima Aemps Name
RANOZEK 750 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG
Register Number
87985
Holder Company Name
Adamed Laboratorios S.L.U.
Marketing Company Name
Adamed Laboratorios S.L.U.
Authorization Date
2022-07-19
Dosage Form
COMPRIMIDO DE LIBERACIÓN PROLONGADA
Dose
750 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Adamed Laboratorios S.L.U.
Active Ingredients
RANOLAZINA
750 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 19, 2022
Approval ID
f40876a7dc6edb70
Type
Standard
Back to CIMA-AEMPS Approvals